Connect with us

CBD

Top German Government Official Previews Marijuana Legalization Plan Details

Published

on

As more states legalize marijuana, the director of the National Intelligence Service (DNI) says federal employers shouldn’t directly reject applicants for a security clearance, but should use discretion when it comes to cannabis investments in their stock portfolios.

DNI Avril Haines’ new memo – following on from past guidelines approved under the Obama administration – says that while cannabis is legalized in states across the country, its use by those in positions that require national security clearance is remains a cause for concern. should be taken into account in the application process.

However, the internal notice distributed to nearly 100 agencies late last month appears to give additional leeway when it comes to prior marijuana use by applicants and employees.

Haines wants federal agencies to “remind civil, military and contractor personnel authorized to gain access to classified information or hold sensitive positions of the importance of continuing compliance with federal laws and regulations” that are currently banning cannabis.

Illegal use of controlled substances, she wrote, “can raise security concerns about the reliability and trustworthiness of a person regarding access to classified information or the perception of a sensitive position and their ability or willingness to comply with laws, rules and regulations.”

However, the document, first published Monday by ClearanceJobs, states that while the federal law on marijuana and a person’s past use “remains relevant” to decisions about “eligibility to access classified information or authorization to.” take a sensitive position. “

This appears to be a notable policy development, as ClearanceJobs reported that there was generally a one to two year abstinence requirement for potential federal employees who need a security clearance with various agencies. The policy could be further amended in the future, Haines noted, if there is a “change to federal marijuana use law”.

For now, state employment judges should look into other factors outside of past marijuana use to see if that particular “concern” should really determine their eligibility, the memo says. These external factors could include the frequency of use and the likelihood that a person will continue to use marijuana.

“In addition, given long-standing federal law and policies prohibiting illicit drug use in a sensitive position or in possession of a security clearance, authorities are encouraged to advise potential national security workers to refrain from any future marijuana use when initiating the.” national security clearance process that begins once the individual has signed the certification contained in Standard Form 86 (SF-86), National Security Positions Questionnaire. “

This means that DNI apparently sent a message that even recent marijuana use could be overlooked as long as the person refrains from later use after completing a certain national safety form.

Interestingly, this new document also talks about cannabis-related investments, unlike an earlier DNI memo on the subject, signed in 2014 by then-DNI James Clapper.

It states that if that person knowingly and directly invests in stocks or business entities specifically related to marijuana growers and retailers, while growing, the ability to access classified information or hold a sensitive position “can be negatively impacted and the distribution of marijuana will remain illegal ”. according to federal law.

People who have not knowingly invested in the cannabis space – by investing their money in mutual funds, for example, where an outside advisor may have invested dollars for the marijuana market – shouldn’t automatically be penalized by federal agencies, DNI said.

In indirect marijuana investments, “judges should assume that the person did not knowingly invest in a marijuana business; therefore the indirect investment should not be viewed as relevant to the decision. “

In other words, DNI provides specific investment-related guidance regarding the marijuana market – a sign of the continued normalization of the industry even under the federal ban.

However, Haines notes that a “decision to invest in an activity, including a marijuana business, that the person knows is in violation of federal law reflects questionable judgment and an unwillingness to comply with laws, rules and regulations could”.

Haines also discussed the use of CBD among federal employees in need of a security clearance. The official admitted that the non-intoxicating cannabinoid could be federally legal if extracted from hemp under the 2018 Farm Bill, but its use could still be “decision-making.”

“In addition, the authorities should be aware that the Federal Drug Administration does not certify the THC content in CBD products so that the THC percentage cannot be guaranteed, which makes the use of a CBD product questionable under federal law,” said it says in the memo. “Studies have shown that some CBD products, regardless of the promotional labels, exceed the 0.3 percent THC limit for hemp.”

“As a result, there is a risk that use of these products could still generate high enough THC levels to test positive for marijuana in government-administered employment or random drug testing programs. If an individual test is positive, they will be subjected to an examination according to the specific guidelines of their home authority. “

This is generally in line with guidelines put in place in several federal agencies since the state legalization of hemp. However, some agencies have stricter rules for CBD.

For example, the Department of Defense made it clear that CBD is taboo for service members.

The Air Force issued a notice in 2019 stating that its members are prohibited from using the site.

The Navy announced to its ranks that regardless of their legal status, they are prohibited from using CBD.

And the Coast Guard said in 2019 that seafarers are not allowed to consume marijuana or visit government pharmacies.

NASA said CBD products could contain unauthorized concentrations of THC that could put jobs at risk if employees fail a drug test.

The Drug Abuse and Mental Health Agency issued guidelines in 2019 for the federal agency’s drug program coordinators, expressing concerns about excess THC in CBD products, which appears to have prompted various departments to clarify their rules.

The Ministry of Transport took a different approach in 2020 and stated in a statement that it would not test drivers for CBD.

For its part, the Drug Enforcement Administration continues its policy of automatically excluding applicants who have used marijuana in the three years prior to applying.

And while the Biden government has put in place a policy giving waivers to certain workers who admit past cannabis use, it has come under fire from advocates after reports of dozens of employees being fired or otherwise punished for being honest with their story Marijuana were.

White House press secretary Jen Psaki has previously tried to minimize the effects to no great extent, and her office released a statement in March stating that no one was fired for “using marijuana years ago” yet someone was laid off for “casual or” infrequent use in the past 12 months. “

Meanwhile, the FBI updated its hiring guidelines last year so that candidates will only be automatically banned from the agency if they admit to having used marijuana within a year of applying. Previously, prospective employees of the agency were not allowed to have consumed cannabis in the past three years.

A powerful congressional committee released a report earlier this summer urging federal agencies to reconsider policies that lead to the sacking of employees who legally use marijuana under state law.

Read the DNI memo on federal guidelines for working with marijuana below:

Former GOP congressman joins psychedelics advocacy group to push for federal reform

Photo courtesy Mike Latimer.

Marijuana Moment is made possible with the support of the readers. If you rely on our cannabis journalism to keep you up to date, please consider making a monthly Patreon Pledge.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

CBD

The Cannabis Renaissance

Published

on

His stigma seems to be fading fast on Indian soil. From a drug provocateur to an alternative cure for creaky joints, insomnia, anxiety and other urban health disorders, cannabis has finally arrived in a sophisticated avatar packaged in essential oils. It has become a #shelfiegoal2022 to have a healing potion powered by CBD oil to get rid of your health problems. Hemp products have clearly overcome the hump of misgivings and misunderstandings on the alternative medicine bandwagon. The cannabis economy is growing.

The medicinal properties of the plant find specific mention in ancient Vedic literature. The Atharva-Veda describes cannabis as a remedy for many diseases. The Sushruta Samhita, dated between the 3rd and 8th centuries BC. BC, advocated the use of cannabis for phlegm and diarrhea. Yet with our shared perception of ganja on the ghats, clay chillums being passed around in puffs of smoke, and hashish conquering the senses, the country has quietly continued, often with, the “psychoactive” cultivation of hemp, a cousin of marijuana religious and medical accents.

Acceptance of the versatile hemp is finally gaining well-deserved ground as cannabis-powered wellness products are sold online and become best-sellers in the industry. “When we started, we had to explain why wearing a hemp shirt doesn’t get you high. Today, people of all generations buy our products and choose to heal themselves holistically through a natural source,” says Yash Kotak, co-founder of Mumbai-based BOHECO Bombay Hemp Company.

Awshad Full Spectrum Vijaya Oil Tulsi

Cannabis offers therapeutic healing and nutrition, and with over 25,000 ways to use this one plant, it’s a solution provided by the most sustainable and eco-friendly resource. “This is definitely just the beginning. We still have many miles to unlock the potential, and with the right kind of R&D practices, the world is at our feet,” says Chirag Tekchandaney, co-founder of BOHECO, adding: “In the last two years, the Income from operations increased by over 25 percent. Before that, we were operating at a three-year compound annual growth rate (CAGR) of 93 percent. The Hemp Fiber and Hemp Seed segments are expected to register substantial CAGRs of 27 percent and 25 percent, respectively, during the forecast period.

The cumulative share of these two segments was 47.6 percent in 2019 and is expected to reach 50.1 percent by 2027. We also export our products to over 10 countries, but most of our D2C audience is from India. Our repeat purchase is highest in this category, with over 43 percent of our target audience coming back to buy more. That says a lot.” This sudden shift has been evident since the lockdowns, leading to more startups in this space. Cannabis has now gained more acceptance, reaching an overtone of “herbal” overtones compared to the source of high it was once labeled as.

There was a time when the arrival at home of a CBD oil-infused supplement freaked out our loved ones. They thought we were on drugs. Now the same people are using it for its many therapeutic purposes. There has been an overall softening of attitude. Nowadays, more players encounter Boomtown. “The growth rate of this industry is directly related to the awareness of the legality, availability and benefits of this plant,” says Richa Jaggi, co-founder of Awshad, which started last year. “I believe this softening of attitudes can be directly linked to the growing popularity of cannabis around the world. Countries like the US and Canada started the cannabis destigmatization movement and funded various research to learn more about it.

They uncovered two things: the plant has various medicinal properties, and its properties were misrepresented,” she adds. Obviously learning is spreading. Loveena Sirohi, Co-Founder and Director of India Hemp Organics based in Bengaluru says: “At IHO, our growth rate has been 200 percent year over year. We have seen a diverse age range of people incorporating hemp and cannabis products into their lifestyle. Today our oldest patient is 94 years old and consumes the Sleep Well CannaBliss oil daily for better sleep.” She adds: “With the outbreak of Covid-19, cannabis-based medicinal oils helped fight a variety of diseases, including Depression and anxiety that increased during lockdown.”

The format and application of the products advertise to a cross-section of the population through oils, balms and creams. “They’re used to treat pain, inflammation, arthritis, pimples, eczema, itchy skin, and more,” says Jaggi, adding, “Cannabis edibles like tinctures and gummies are more geared towards men and women over the age of 18 who are.” suffering from insomnia, stress, anxiety, chronic pain, bowel problems, etc. People suffering from epilepsy or undergoing chemotherapy swear by this product.” alive and well the natural way the right way. But a word of caution: Cannabis leaf falls under a Schedule E-1 drug under the Drugs and Cosmetics Rules of 1945, and any medication containing a Schedule E-1 substance must be taken under medical supervision.

THE HOLY TRUTH

✥ Look for the licensed stamp of the Ministry of AYUSH, Government of India on the products
✥ Cannabis-infused medicines are safe to use and non-addictive, especially when taken under medical supervision
✥ The expensive labels are due to the difficult supply chain as hemp is mainly grown in Uttarakhand in the foothills of the Himalayas

Continue Reading

CBD

The Cannabis Renaissance- The New Indian Express

Published

on

Express Message Service

His stigma seems to be fading fast on Indian soil. From a drug provocateur to an alternative cure for creaky joints, insomnia, anxiety and other urban health disorders, cannabis has finally arrived in a sophisticated avatar packaged in essential oils. It has become a #shelfiegoal2022 to have a healing potion powered by CBD oil to get rid of your health problems. Hemp products have clearly overcome the hump of misgivings and misunderstandings on the alternative medicine bandwagon. The cannabis economy is growing.

The medicinal properties of the plant find specific mention in ancient Vedic literature. The Atharva-Veda describes cannabis as a remedy for many diseases. The Sushruta Samhita, dated between the 3rd and 8th centuries BC. BC, advocated the use of cannabis for phlegm and diarrhea. Yet with our shared perception of ganja on the ghats, clay chillums being passed around in puffs of smoke, and hashish conquering the senses, the country has quietly continued, often with, the “psychoactive” cultivation of hemp, a cousin of marijuana religious and medical accents.

Acceptance of the versatile hemp is finally gaining well-deserved ground as cannabis-powered wellness products are sold online and become best-sellers in the industry. “When we started, we had to explain why wearing a hemp shirt doesn’t get you high. Today, people of all generations buy our products and choose to heal themselves holistically through a natural source,” says Yash Kotak, co-founder of Mumbai-based BOHECO Bombay Hemp Company.

Awshad Full Spectrum Vijaya Oil Tulsi

Cannabis offers therapeutic healing and nutrition, and with over 25,000 ways to use this one plant, it’s a solution provided by the most sustainable and eco-friendly resource. “This is definitely just the beginning. We still have many miles to unlock the potential, and with the right kind of R&D practices, the world is at our feet,” says Chirag Tekchandaney, co-founder of BOHECO, adding: “In the last two years, the Income from operations increased by over 25 percent. Before that, we were operating at a three-year compound annual growth rate (CAGR) of 93 percent. The Hemp Fiber and Hemp Seed segments are expected to register substantial CAGRs of 27 percent and 25 percent, respectively, during the forecast period.

The cumulative share of these two segments was 47.6 percent in 2019 and is expected to reach 50.1 percent by 2027. We also export our products to over 10 countries, but most of our D2C audience is from India. Our repeat purchase is highest in this category, with over 43 percent of our target audience coming back to buy more. That says a lot.” This sudden shift has been evident since the lockdowns, leading to more startups in this space. Cannabis has now gained more acceptance, reaching an overtone of “herbal” overtones compared to the source of high it was once labeled as.

There was a time when the arrival at home of a CBD oil-infused supplement freaked out our loved ones. They thought we were on drugs. Now the same people are using it for its many therapeutic purposes. There has been an overall softening of attitude. Nowadays, more players encounter Boomtown. “The growth rate of this industry is directly related to the awareness of the legality, availability and benefits of this plant,” says Richa Jaggi, co-founder of Awshad, which started last year. “I believe this softening of attitudes can be directly linked to the growing popularity of cannabis around the world. Countries like the US and Canada started the cannabis destigmatization movement and funded various research to learn more about it.

They uncovered two things: the plant has various medicinal properties, and its properties were misrepresented,” she adds. Obviously learning is spreading. Loveena Sirohi, Co-Founder and Director of India Hemp Organics based in Bengaluru says: “At IHO, our growth rate has been 200 percent year over year. We have seen a diverse age range of people incorporating hemp and cannabis products into their lifestyle. Today our oldest patient is 94 years old and consumes the Sleep Well CannaBliss oil daily for better sleep.” She adds: “With the outbreak of Covid-19, cannabis-based medicinal oils helped fight a variety of diseases, including Depression and anxiety that increased during lockdown.”

The format and application of the products advertise to a cross-section of the population through oils, balms and creams. “They’re used to treat pain, inflammation, arthritis, pimples, eczema, itchy skin, and more,” says Jaggi, adding, “Cannabis edibles like tinctures and gummies are more geared towards men and women over the age of 18 who are.” suffering from insomnia, stress, anxiety, chronic pain, bowel problems, etc. People suffering from epilepsy or undergoing chemotherapy swear by this product.” alive and well the natural way the right way. But a word of caution: Cannabis leaf falls under a Schedule E-1 drug under the Drugs and Cosmetics Rules of 1945, and any medication containing a Schedule E-1 substance must be taken under medical supervision.

THE HOLY TRUTH

✥ Look for the licensed stamp of the Ministry of AYUSH, Government of India on the products
✥ Cannabis-infused medicines are safe to use and non-addictive, especially when taken under medical supervision
✥ The expensive labels are due to the difficult supply chain as hemp is mainly grown in Uttarakhand in the foothills of the Himalayas

Continue Reading

CBD

RESET Bioscience Debuts Bioavailable Pet CBD Drops

Published

on

AUSTIN, Texas, Jan. 13, 2022 /PRNewswire/ — RESET Bioscience, an advanced wellness company utilizing pharmaceutical-grade ingredients and technology, is introducing CBD drops for pets to its portfolio.

Developed by leading Ph.D. Scientists are RESET Pet CBD Drops the world’s first water-based ingestible CBD for pets Powered by Santé® Delivery Technology for fast, maximum absorption and double tested to human standards.

The same lipid encapsulation technology that pioneered RESET’s wellness products is now being applied to pet products. RESET’s highly bioavailable drops can be conveniently added to your pet’s food, favorite treat or even your pet’s water bowl with no separation required as the formula is water based.

“As a proud mommy of dogs, my pets are an extension of my family and their health and well-being are of the utmost importance,” said Ashley Ferguson, President of RESET. “I wanted to use CBD pet treats to support my elderly Chihuahua’s quality of life and calm my anxious Doberman puppy at home. Before introducing RESET, I tested treats and oils from major brands on the market at a leading analysis lab. I was beyond shocked and disappointed to find alarming levels of heavy metals like lead, mercury and even arsenic, residual solvents and microbiological contaminants like E. coli and salmonella in almost every product. that I was recommended to dose my Chihuahua the same amount as my Doberman!

We immediately felt compelled to bring to market a pet product with human ingredients protected by our world-class testing and saw an opportunity to apply RESET’s delivery system in partnership with Powered by Santé® Deployment Technology. Technology differentiates RESET Pet by providing faster, better absorption for more immediate results and safer dosing in accordance with a pet’s weight. With this water-based formula, pet parents can have peace of mind at any dosage, while with oils you risk liver toxicity as small livers do not process oil well. We are constantly focused on the next generation of wellness and are proud to extend this to animal health.”

Like humans, cats and dogs can take full advantage of the interaction between CBD and the endocannabinoid system. Because of this, CBD can have positive effects on everything from mood, to mind and body support, to general well-being. RESET is thrilled to offer ecommerce shoppers award-winning CBD relief for their furry friends.

RESET’s latest advancement features traceable premium ingredients that are lab tested to ensure potency, purity and consistency. Designed for maximum bioavailability, Pet CBD Drops come in a pet-approved pumpkin flavor to wag those tails!

About RESET Pet CBD Drops:

  • 5 mg highly bioavailable CBD per 0.5 ml, 150 mg per bottle
  • Hemp-derived cannabidiol (CBD) extracted from premium hemp grown in the USA. THC-free (tested less than 0.001% THC)
  • Contains a delimited dropper for accurate and precise dosing
  • Laboratory tested to ensure potency, purity and consistency
  • Safety sealed to protect your pet. Store at room temperature with the bottle closed
  • Made in the USA

RESET Pet CBD Drops can be added to your pet’s water, food, or favorite treat, but RESET suggests avoiding dropper contact with snoots. With user-friendly dosing based on pet weight, pet owners can be confident in the amount of CBD being administered to their pets.

For more information about RESET Pet CBD Drops, please visit RESETbioscience.com and follow @RESETbioscience on Instagram, TikTok and Facebook.

About RESET: RESET products with Powered by Santé® Delivery Technology, empowers you to RESET your wellness ritual with powerful solutions that support you from dawn to dusk. Engineered for maximum bioavailability of premium ingredients and uniquely water-based, like your body, RESET products are expertly blended by Ph.D. Scientists need to go where you need it (in your small intestine) so you can actually absorb it. Inspired by nature and backed by science, their line of wellness products is formulated and tested to pharmaceutical standards and proven to last over 12 months.

Current awards:

*Tested for less than 0.001% THC

View original content: https://www.prnewswire.com/news-releases/reset-bioscience-debuts-bioavailable-pet-cbd-drops-301460773.html

RESET SOURCE Life Sciences

Continue Reading
Advertisement

Trending